🇺🇸 FDA
Pipeline program

ASPRO 320 mg, comprimé, CALCIUM HYDROGEN PHOSPHATE DIHYDRATE, DICLOFENAC ARROW 1 %, gel en flacon pressurisé

DR200091

Phase 3 small_molecule active

Quick answer

ASPRO 320 mg, comprimé, CALCIUM HYDROGEN PHOSPHATE DIHYDRATE, DICLOFENAC ARROW 1 %, gel en flacon pressurisé for Thrombotic episodes in superficial venous malformations in children is a Phase 3 program (small_molecule) at Tour Hekla with 1 ClinicalTrials.gov record(s).

Program details

Company
Tour Hekla
Indication
Thrombotic episodes in superficial venous malformations in children
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials